Global Boron Neutron Capture Therapy (BNCT) Market Growth (Status and Outlook) 2024-2030

Global Boron Neutron Capture Therapy (BNCT) Market Growth (Status and Outlook) 2024-2030

Boron Neutron Capture Therapy (BNCT) is a radiation science which is emerging as a hopeful tool in treating cancer, by selectively concentrating boron compounds in tumour cells and then subjecting the tumour cells to epithermal neutron beam radiation.

The global Boron Neutron Capture Therapy (BNCT) market size is projected to grow from US$ 265 million in 2024 to US$ 2298 million in 2030; it is expected to grow at a CAGR of 43.3% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Boron Neutron Capture Therapy (BNCT) Industry Forecast” looks at past sales and reviews total world Boron Neutron Capture Therapy (BNCT) sales in 2022, providing a comprehensive analysis by region and market sector of projected Boron Neutron Capture Therapy (BNCT) sales for 2023 through 2029. With Boron Neutron Capture Therapy (BNCT) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Boron Neutron Capture Therapy (BNCT) industry.

This Insight Report provides a comprehensive analysis of the global Boron Neutron Capture Therapy (BNCT) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Boron Neutron Capture Therapy (BNCT) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Boron Neutron Capture Therapy (BNCT) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Boron Neutron Capture Therapy (BNCT) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Boron Neutron Capture Therapy (BNCT).

The major global manufacturers of Boron Neutron Capture Therapy (BNCT) include Neutron Therapeutics, Sumitomo Heavy Industries, RaySearch, etc. The world's top three players account for approximately 30% of the market share. Europe is the largest market, with a share about 64%, followed by North America and Asia-Pacific, with share21% and 13%, separately. In terms of product type, Equipment is the largest segment, occupied for a share of 61%. And in terms of application, Head and Neck Cancer has a share about 61 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Boron Neutron Capture Therapy (BNCT) market by product type, application, key players and key regions and countries.

Segmentation by Type:
Equipment
Solution
Drug

Segmentation by Application:
Head and Neck Cancer
Brain Tumor
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Equipment
Solution
Drug

Segmentation by Application:
Head and Neck Cancer
Brain Tumor
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Neutron Therapeutics
Sumitomo Heavy Industries
International Particle Therapy Inc (IPT)
RaySearch
Neuboron Medtech
TAE Life Sciences
Stella Pharma

Please note: The report will take approximately 2 business days to prepare and deliver.